Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selecting patients for long-acting novel antipsychotic therapy.

Tim Lambert1

  • 1Office for Psychiatric Evaluation and Educational Newmedia, University of Melbourne and Orygen Youth Health, Parkville, Vic., Australia. lambertt@unimelb.edu.au

Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|April 25, 2006
PubMed
Summary

Selecting appropriate patients for long-acting novel antipsychotics is crucial for effective schizophrenia management. This study presents six profiles to guide the selection of suitable candidates for these advanced treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Core food group intake in people with enduring psychotic illness accessing community mental health services.

PLOS mental health·2026
Same author

Understanding the Oral Health Status and Factors Affecting Poor Oral Health in People Living With Severe Mental Illness: A Cross-Sectional Study.

Australian dental journal·2025
Same author

Discordance Between Triglycerides, Remnant Cholesterol and Systemic Inflammation in Patients with Schizophrenia.

Biomedicines·2025
Same author

Triglyceride-rich lipoprotein, remnant cholesterol, and apolipoproteins CII, CIII, and E in patients with schizophrenia.

Journal of lipid research·2024
Same author

Pharmacokinetics and Effects on Saliva Flow of Sublingual and Oral Atropine in Clozapine-Treated and Healthy Adults: An Interventional Cross-Over Study.

Psychiatry and clinical psychopharmacology·2024
Same author

Prevalence of, and factors associated with, diabetes mellitus in people with severe mental illness attending a multidisciplinary, outpatient cardiometabolic health assessment service.

BMJ open diabetes research & care·2023

Area of Science:

  • Psychopharmacology
  • Schizophrenia Treatment

Background:

  • Inappropriate patient selection for new psychopharmacological agents can lead to poor outcomes in schizophrenia management.
  • Long-acting novel antipsychotics offer improved adherence and benefits of second-generation antipsychotics.

Purpose of the Study:

  • To present six patient selection profiles for long-acting novel antipsychotics in schizophrenia.
  • To guide appropriate patient selection for improved treatment outcomes.

Main Methods:

  • Utilized criteria from a large clinical network in Victoria, Australia.
  • Developed six distinct patient profiles for suitability assessment.

Main Results:

  • Six patient selection profiles for long-acting novel antipsychotics were identified.

Related Experiment Videos

  • These profiles aim to optimize candidate selection for improved treatment efficacy.

    • Conclusions:

    • Optimizing outcomes in schizophrenia requires a stable psychopharmacological foundation.
    • Long-acting novel antipsychotics enhance adherence, supporting recovery. Identifying suitable patients improves recovery efficiency.